linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Natco Pharma Ltd.
 
Industry : Pharmaceuticals & Drugs House : Natco
BSE Code 524816
ISIN Demat INE987B01026
Book Value 467.76
NSE Code NATCOPHARM
Dividend Yield % 0.58
Market Cap 184098.08
P/E 12.27
EPS 83.75
Face Value 2  
 
Incorporation Year 19-09 1981  
Registered Office Natco House,Road No 2,Banjara Hills, Hyderabad,
Telangana-500034 .
ISINNO INE987B01026  
Phone 040-23547532  
E-mail investors@natcopharma.co.in / dasaradhi@natcopharma.co.in
URL www.natcopharma.co.in
Industry Pharmaceuticals & Drugs  
Chairman V C Nannapaneni  
Managing Director V C Nannapaneni  
Company Secretary Chekuri Venkat Ramesh  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.